AzTrials
AzTrials

Cervical RipeningNCT05864326

Heated Saline in Cervical Balloon for Labor Induction, a RCT

A study testing Warm group and Room temperature group in people with Cervical Ripening and Induction of Labor, run by Begona Martinez de Tejada at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is a single-center, randomized, two-arm, controlled trial, including women requiring cervical ripening during the process Induction of Labor using Balloon catheter (BC). Read more about this study

Who is it for?
Ages 16 years and older, women onlyHealthy volunteers can take part
What is being tested?
Warm group and Room temperature group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
290 participants
Where
1 siteSwitzerland
Study dates
16 Oct 2023to 30 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Gestational age at or over 35 weeks
  • Singleton pregnancy
  • Alive fetus
  • Cephalic presentation
  • Maternal age ≥ 16 years

Who cannot join

  • Active labor (dilated cervix with spontaneous uterine contractions)
  • Prelabor rupture of membranes
  • >1 Previous cesarean delivery
  • Fetal malformation leading to a possible obstruction of labor (e.g., hydrocephaly, exteriorized fetal tumors, etc.)
  • Maternal or fetal disease with indication to accelerate labor (start oxytocin stimulation within 6 hours after insertion of the BC (e.g., pre-eclampsia, chorioamnionitis, etc.)]
  • Counterindication to vaginal delivery
  • Impossibility to give consent to participation

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Hôpitaux Universitaires de Genève

    Geneva, Canton of Geneva, 1205

Other trials in Switzerland

About this study

Official title: Effect of Heated Saline in Duration of Cervical Ripening in Women Having Labor Induction With Cervical Balloon: a Randomized Controlled Study

This study is a single-center, randomized, two-arm, controlled trial, including women requiring cervical ripening during the process Induction of Labor using Balloon catheter (BC). The primary objective of the study is to determine if the use of heated saline in the BC used for cervical ripening reduces the length of BC duration.

Participants will be allocated to :

  • Intervention or warm group: the BC will be filled with heated saline water up to 40° C
  • Standard or room temperature group: the BC will be filled with saline water at room temperature.
Read the detailed description

Background and Rationale:

Induction of Labor (IOL) is one of the most common interventions in obstetrics. IOL is performed due to fetal, maternal or pregnancy complications to reduce the risk of complication. IOL methods will depend of the state of the cervix at the beginning of the procedure. If cervix is considered unfavorable (Bishop score ≤ 5) an initial phase of ripening is usually proposed. There are various methods of cervical ripening, which can be divided into non-pharmacological (e.g., mechanical methods with transcervical Foley catheter or Cook balloon) and pharmacological (e.g., prostaglandins). IOL can be a long-lasting procedure, especially when cervical ripening is necessary.

Two recent, small studies have shown that the use of warm fluid to inflate the balloon catheter (BC) inserted through the cervix reduces the time of cervical ripening, hence potentially reducing the time of IOL. These results are the only data available regarding the use of saline at different temperatures for inflating the balloon in mechanical methods and show promising effects in terms of reduction in the length of the cervical ripening and labor.

The cervix is mainly composed of collagen. Studies show that the use of heat on connective tissue increase the potential elongation of collagen tissue and the denaturation of this protein.

We hypothesize that the use of heat in the cervical ripening can accelerate the denaturation of the collagen and accelerate the softening of the cervix and therefore reduce the duration of cervical ripening and labor.

Objective(s):

The primary objective of the study is to determine if the use of heated saline in the BC used for cervical ripening reduces the length of BC duration, defined as the time from the insertion to the expulsion or artificial removal of the BC.

The secondary objectives are to evaluate if the use of heated saline compared with room temperature:

  1. Decreases the length from the start of the induction until the achievement of a favorable cervix (Bishop score >5).
  2. Decreases the length from the start of the induction until full dilation
  3. Decreases the length from the start of the induction until delivery
  4. Increases the rate and the speed of spontaneous rupture of membranes (ROM) during cervical ripening
  5. Impacts on the rate of cesarean delivery.
  6. Impacts on the pain and the satisfaction in women undergoing cervical ripening
  7. Impacts on obstetrical and neonatal complications

Study Design:

Prospective, single-center, randomized, two-arm, controlled trial, including women requiring cervical ripening during the process IOL using Balloon catheter

Number of Participants with Rationale:

A total of 290 women will be recruited (145 women in each group) in order to show a reduction in the duration of BC placement, considering a significance criterion set to 0.05 (alpha, two- tailed), and an expected power of at least 90%.

Study procedures:

Patients will be allocated in one of this two groups:

  • Intervention or warm group: the BC will be filled with heated saline water up to 40° C
  • Standard or room temperature group: the BC will be filled with saline water at room temperature.

In both groups, the insertion of the BC will be done following the same procedure:

The operator will introduce a 14Fr or 18Fr Balloon catheter through the cervical canal, up above the internal orifice using a long Pean clamp and inflate the internal balloon with 30 to 80ml of saline water (NaCl 0.9%) -either heated or unheated, depending on the allocation group- according to the mechanic resistance with a graduated syringe.

Statistical Considerations Main analysis will be performed on an intention-to-treat basis. The main outcome will be evaluated by plotting survival functions according to the allocation group, using the Kaplan-Meier estimator. The associations will be considered as statistically significant when the p-value is below 0.05 (probability of type I error = 0.05). This analysis is also planned for objectives 2 (interval from beginning of IOL and achievement of a favorable cervix) and 3 (interval from beginning of IOL and delivery). For the other outcomes, comparison will be performed using Fisher's exact test, Student's t-test or the Mann-Whitney U test, according to the type of variable.

Being tested
Warm group, Room temperature group
Keywords
Cervical ripening, Induction of Labor, Unfavorable cervix, Mechanical method

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Warm groupDevice

    The operator will introduce a 14Fr or 18Fr Balloon catheter through the cervical canal, up above the internal orifice using a long Pean clamp and inflate the internal balloon with 30 to 80ml of Heated saline water (NaCl 0.9%) at 40°C - according to the mechanic resistance with a graduated syringe.

  • Room temperature groupDevice

    The operator will introduce a 14Fr or 18Fr Balloon catheter through the cervical canal, up above the internal orifice using a long Pean clamp and inflate the internal balloon with 30 to 80ml of unheated saline water (NaCl 0.9%) - according to the mechanic resistance with a graduated syringe.

Study groups in NCT05864326
Study groupRoleWhat they receive
Warm groupExperimentalThe Balloon Catheter will be filled with heated saline water up to 40° C
Receives: Device: Warm group
Room temperature groupActive comparatorthe Balloon Catheter will be filled with saline water at room temperature.
Receives: Device: Room temperature group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To determine if the use of heated saline in the Balloon Catheter (BC), used for cervical ripening, reduces the length of BC duration, defined as the time from the insertion to spontaneous expulsion or artificial removal of the BC.

    Duration of BC (i.e., positioning of the transcervical catheter): interval between insertion and retrieval, either after spontaneous expulsion or artificial retrieval.

    Measured: Through study completion, an average of 1.5 years

Secondary outcomes (7)
  1. To evaluate if the use of heated saline compared with room temperature Decreases the length from the start of the induction until the achievement of a favorable cervix (Bishop score >5)

    Length of cervical ripening phase, defined as the interval between catheter insertion and the achievement of a favorable cervix, defined as Bishop score >5.

    Measured: Through study completion, an average of 1.5 years

  2. Decreases the length from the start of the induction until full dilation

    Length from the start of the BC insertion until fully dilation

    Measured: Through study completion, an average of 1.5 years

  3. Decreases the length from the start of the induction until the delivery

    Length from the start of the BC insertion until the delivery

    Measured: Through study completion, an average of 1.5 years

  4. Increases the rate and the speed of spontaneous rupture of membranes (ROM) during cervical ripening

    Spontaneous rupture of membranes (ROM) during cervical ripening or labor (Yes/No)

    • If Yes, length from the insertion of the BC until spontaneous ROM.

    Measured: Through study completion, an average of 1.5 years

  5. Impacts on the rate of cesarean delivery

    Mode of delivery (vaginal delivery vs. cesarean delivery)

    Measured: Through study completion, an average of 1.5 years

  6. Impacts on the pain and the satisfaction in women undergoing cervical ripening

    Pain after catheter insertion assessed using a numeric rating scale (NRS, where NRS = 0 equals no pain and NRS = 10 represents the worst possible pain suffered by the participant). Participants satisfaction of the whole using a five-point Likert scale (1, very dissatisfied; 2, dissatisfied; 3, Enough Satisfied; 4, Satisfied; and 5, very satisfied)

    Measured: Through study completion, an average of 1.5 years

  7. Impacts on obstetrical and neonatal complications

    Presence of obstetrical complications or neonatal complications

    Measured: Through study completion, an average of 1.5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 May 2023
  2. Study start16 Oct 2023
  3. Primary completion30 May 2025
  4. Study completion30 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Model description
Prospective, single-center, randomized, two-arm, controlled trial, including women requiring cervical ripening during the process IOL using Balloon catheter
Masking
None (open label)
Enrolment
290 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05864326
Sponsor's protocol ID
2022-02120
Status last verified
Jun 2025
First submitted
2 Apr 2023
Last updated
5 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Warm group and Room temperature group in people with Cervical Ripening and Induction of Labor, run by Begona Martinez de Tejada at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To determine if the use of heated saline in the Balloon Catheter (BC), used for cervical ripening, reduces the length of BC duration, defined as the time from the insertion to spontaneous expulsion or artificial removal of the BC. (time frame: Through study completion, an average of 1.5 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in